Appendix A1.
The odds ratios (OR) and 95% confidence intervals (CI) calculated, using conditional logistic regression modeling, as the ratio of the proportion of children exposed to maternal autoimmune disease and its medication in offspring with childhood cancer (cases) and the proportion of exposure to maternal autoimmune disease and its medication in healthy offspring (controls), 1996–2014. Both crude and adjusted ORs are presented. Stratified, unmatched analysis by sex and birth year.
N cases (%) | N controls (%) | Crude OR | 95% CI | Adj. OR | 95% CI | |
---|---|---|---|---|---|---|
No autoimmune disease | 1.00 | --- | 1.00 | --- | ||
Any autoimmune disease | 19 (0.9) | 134 (1.3) | 0.68 | 0.42–1.12 | 0.70 | 0.43–1.15 |
IBD | 12 (0.6) | 61 (0.6) | 1.01 | 0.54–1.89 | 1.07 | 0.57–2.00 |
Rheumatic disease | 7(0.3) | 74 (0.7) | 0.41 | 0.18–0.94 | 0.41 | 0.18–0.94 |
No AI medication purchases | 1.00 | --- | 1.00 | --- | ||
Any AI medication purchase | 169 (8.3) | 888 (8.8) | 0.95 | 0.80–1.13 | 0.96 | 0.80–1.14 |
IBD medication | 13 (0.6) | 65 (0.6) | 1.01 | 0.56–1.84 | 1.07 | 0.59–1.95 |
Systemic corticosteroids | 21(1.0) | 107 (1.1) | 0.91 | 0.56–1.49 | 0.93 | 0.57–1.52 |
Immunosuppressants | 3 (0.1) | 13 (0.1) | 0.83 | 0.19–3.72 | 0.90 | 0.20–4.06 |
Anti-inflammatory and -rheumatic products | 141 (6.9) | 761 (7.5) | 0.93 | 0.77–1.13 | 0.93 | 0.77–1.13 |
Stratified, unadjusted analysis
Stratified analysis adjusted for maternal age (categorized), parity and smoking status.